URATE-LOWERING THERAPY

You have access
Management of Gout in a Hospital Setting: A Lost Opportunity
Sarah Wright, Peter T. Chapman, Christopher Frampton, John L. O’Donnell, Rafi Raja and Lisa K. Stamp

The Journal of Rheumatology October 1 2017, 44 (10) 1493-1498; DOI: https://doi.org/10.3899/jrheum.170387
Open Access
Patients with Gout Treated with Conventional Urate-lowering Therapy: Association with Disease Control, Health-related Quality of Life, and Work Productivity
Robert Wood, Steve Fermer, Sulabha Ramachandran, Scott Baumgartner and Robert Morlock

The Journal of Rheumatology October 1 2016, 43 (10) 1897-1903; DOI: https://doi.org/10.3899/jrheum.151199
You have access
Effect of Urate-lowering Therapy on the Risk of Cardiovascular Disease and All-cause Mortality in Patients with Gout: A Case-matched Cohort Study
Jiunn-Horng Chen, Joung-Liang Lan, Chi-Fung Cheng, Wen-Miin Liang, Hsiao-Yi Lin, Gregory J. Tsay, Wen-Ting Yeh and Wen-Harn Pan

The Journal of Rheumatology September 1 2015, 42 (9) 1694-1701; DOI: https://doi.org/10.3899/jrheum.141542
You have access
Preventing Attacks of Acute Gout When Introducing Urate-Lowering Therapy: A Systematic Literature Review
Rakhi Seth, Alison S.R. Kydd, Louise Falzon, Claire Bombardier, Désirée M. van der Heijde and Christopher J. Edwards

The Journal of Rheumatology Supplement September 1 2014, 92 42-47; DOI: https://doi.org/10.3899/jrheum.140461
You have access
Effect of Urate-lowering Therapies on Renal Disease Progression in Patients with Hyperuricemia
Gerald D. Levy, Nazia Rashid, Fang Niu and T. Craig Cheetham

The Journal of Rheumatology May 1 2014, 41 (5) 955-962; DOI: https://doi.org/10.3899/jrheum.131159

Main menu

User menu

Search

URATE-LOWERING THERAPY

Content

Resources

Subscribers

More